Transplant Rejection News from Send2Press Newswire

Transplant Rejection News

News items related to Transplant Rejection as issued by the Send2Press Newswire service on behalf of the noted news source.

Pure Transplant Solutions, LLC and Vall d’Hebron University Hospital Announce Research Collaboration

Tue, 15 Feb 2022, 09:00:42 EST | From: Pure Transplant Solutions LLC

AUSTIN, Texas and BARCELONA, Spain, Feb. 15, 2022 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d’Hebron Barcelona Hospital Campus to develop new technologies for B-cell monitoring in transplant rejection.

Pure Transplant Solutions Announces Collaboration with Innobiochips to Develop Personalized Diagnostics for Post-Transplant Monitoring and Early Detection of Transplant Rejection

Wed, 24 Mar 2021, 07:00:52 EDT | From: Pure Transplant Solutions LLC

AUSTIN, Texas and LOOS, France, March 24, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Innobiochips (IBC).

Pure Transplant Solutions Announces Collaboration with Northwestern University to Develop Novel Reagents for Enhanced Characterization of HLA DQ Antigens in Transplant Rejection

Wed, 17 Mar 2021, 07:00:28 EDT | From: Pure Transplant Solutions LLC

AUSTIN, Texas and EVANSTON, Ill., March 17, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with Northwestern University, a world leader in HLA DQ antigen research.

Pure Transplant Solutions, LLC and University Hospital Basel Announce Research Collaboration

Wed, 27 Jan 2021, 07:00:57 EST | From: Pure Transplant Solutions LLC

AUSTIN, Texas and BASEL, Switzerland, Jan. 27, 2021 (SEND2PRESS NEWSWIRE) — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The Transplantation Immunology & Nephrology Department of the University Hospital of Basel.